SWAINSONINE, AN INHIBITOR OF MANNOSIDASE-II DURING GLYCOPROTEIN PROCESSING, ENHANCES CONCANAVALIN-A-INDUCED T-CELL PROLIFERATION AND INTERLEUKIN-2 RECEPTOR EXPRESSION EXCLUSIVELY VIA THE T-CELL RECEPTOR COMPLEX

被引:19
作者
BOWLIN, TL
SCHROEDER, KK
FANGER, BO
机构
[1] Marion Merrell Dow Research Institute, Cincinnati, OH 45215
关键词
D O I
10.1016/0008-8749(91)90061-F
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The T cell receptor (TCR) is a disulfide-linked heterodimer consisting of both complex and high-mannose types of N-linked oligosaccharides. The objective of the present investigation was to examine the effect of altered oligosaccharide structure on the expression and function of the TCR. Human mononuclear lymphocytes (MNL) were treated with castanospermine (CAST) or swainsonine (SW), inhibitors of glucosidase I or mannosidase II, respectively. Treatment with these inhibitors does not prevent glycosylation, but results in synthesis of glycoproteins with highmannose or hybrid types of oligosaccharides. Treatment of MNL with CAST (1000-10 μM) or SW (100-1 μM) for up to 72 hr had no effect on cell surface expression of the TCR. SW potentiated Con A-induced T cell proliferation without effecting anti-CD3 (OKT3) or alloantigen-induced proliferation. CAST had no effect on Con A, anti-CD3, or alloantigen-induced T cell proliferation. The T cell proliferative response to Con A in the presence of SW was completely eliminated in the presence of monoclonal anti-TCR antibodies. Monoclonal anti-CD2, -CD3, -CD4, -CDS, or isotypic control monoclonal antibodies had no effect on SW enhancement of T cell proliferation. SW treatment potentiated Con A-induced MNL expression of both the α and β subunits of the IL 2R. This effect was also specifically blocked by anti-TCR monoclonal antibodies. These results demonstrate that selective changes in the glycosylation state of the TCR complex can alter mitogen recognition and subsequent cellular activation. © 1991.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 29 条
[11]  
Grzegorzewski K, 1989, Cancer Commun, V1, P373
[12]  
HINO M, 1985, J ANTIBIOT, V28, P916
[13]   GLYCOSYLATION OF THE T-CELL ANTIGEN-SPECIFIC RECEPTOR AND ITS POTENTIAL ROLE IN LECTIN-MEDIATED CYTOTOXICITY [J].
HUBBARD, SC ;
KRANZ, DM ;
LONGMORE, GD ;
SITKOVSKY, MV ;
EISEN, HN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1852-1856
[14]  
HUMPHRIES MJ, 1988, CANCER RES, V48, P1410
[15]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[16]   A MONOCLONAL-ANTIBODY THAT APPEARS TO RECOGNIZE THE RECEPTOR FOR HUMAN T-CELL GROWTH-FACTOR - PARTIAL CHARACTERIZATION OF THE RECEPTOR [J].
LEONARD, WJ ;
DEPPER, JM ;
UCHIYAMA, T ;
SMITH, KA ;
WALDMANN, TA ;
GREENE, WC .
NATURE, 1982, 300 (5889) :267-269
[17]  
LIU P, 1986, Patent No. 202661
[18]  
MYC A, 1989, CANCER RES, V49, P2879
[19]   T-CELL GROWTH-FACTOR RECEPTORS - QUANTITATION, SPECIFICITY, AND BIOLOGICAL RELEVANCE [J].
ROBB, RJ ;
MUNCK, A ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (05) :1455-1474
[20]   EVIDENCE FOR A PHYSICAL ASSOCIATION OF CD4 AND THE CD3-ALPHA-BETA-T-CELL RECEPTOR [J].
SAIZAWA, K ;
ROJO, J ;
JANEWAY, CA .
NATURE, 1987, 328 (6127) :260-263